Filtered By:
Procedure: Gastroschisis Repair
This page shows you your search results in order of relevance. This is page number 5.
Order by Relevance | Date
Total 67467 results found since Jan 2013.
UCSF Medical Center Ranked Eighth Nationally By U.S. News
Dr. Jason Pomerantz and Dr. Carrie McCloskey repair a patient's jaw bone at UCSF Medical Center. Photo by Susan Merrell
UCSF Medical Center is among the nation's premier hospitals for the 13th consecutive year, ranking as the eighth best hospital in the country in the 2014-2015 America's Best Hospitals survey from U.S. News & World Report, and once again securing a spot among the top 10 hospitals nationwide.
Source: UCSF Medical Center - July 17, 2014 Category: Universities & Medical Training Authors: webservices at ucsfhealth.org Source Type: news
Impact evaluation of Swiss Medical Board reports on routine care in Switzerland: a case study of PSA screening and treatment for rupture of anterior cruciate ligament.
CONCLUSIONS: Despite some evidence of a possible change, we did not find a sustained and significant impact of SMB recommendations in our case study. Further monitoring is needed to confirm or refute these findings.
PMID: 26024476 [PubMed - as supplied by publisher]
Source: Swiss Medical Weekly - May 31, 2015 Category: Journals (General) Authors: Eichler K, Hess S, Riguzzi M, Can Ü, Brügger U Tags: Swiss Med Wkly Source Type: research
Integra LifeSciences picks up TEI Biosciences, TEI Medical for $312m
Integra LifeSciences (NSDQ:IART) said yesterday that it agreed to acquire TEI Biosciences and sister company TEI Medical for $312 million in cash in a bid to expand its footprint in reconstructive surgery and regenerative wound care.
The deal, expected to close during the 3rd quarter, brings TEI’s PriMatrix dermal repair scaffold and a 125-member sales force under the Integra umbrella, that Plainsboro, N.J.-based company said. TEI is based in Waltham, Mass.
“This acquisition broadens our presence in regenerative wound care and tissue repair and represents a significant push forward toward our growth objectiv...
Source: Mass Device - June 29, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Regenerative Medicine Integra LifeSciences Corp. TEI Biosciences TEI Medical Source Type: news
Lombard Medical debuts latest Aorfix stent graft
Lombard Medical Technologies (NSDQ:EVAR) today announced the debut of its Aorfix Plus stent graft for endovascular repair of abdominal aortic aneurysms.
The Aorfix Plus, designed to treat larger-size AAAs, won 510(k) clearance from the FDA for the device in February.
Irvine, Calif.-based Lombard said the 1st clinical cases using the device were successfully completed at sites including the Loma Linda Veterans Administration Hospital in California and Blount Memorial Hospital in Merryville, Tenn.
“I find the stent graft extremely easy to deploy making the placement very predictable,” Blount Memorial’s...
Source: Mass Device - June 30, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Stent Grafts Lombard Medical Technologies Source Type: news
Lombard Medical looks to M&A to grow beyond AorFix
Lombard Medical Technologies (NSDQ:EVAR) CEO Simon Hubbert this week said the stent graft maker is looking beyond the abdominal aortic aneurysm repair market, aiming to grow out of being a 1-product company either via acquisition or a distribution deal with a larger medical device company.
Discussing Lombard’s 2nd-quarter results July 27, Hubbert referenced the $110 million buyout of Aptus Endosystems by Medtronic (NYSE:MDT) last month, observing that the crowded and competitive abdominal aortic aneurysm repair market is driving consolidation.
“We believe this environment presents us with the opportunit...
Source: Mass Device - July 29, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: MassDevice Earnings Roundup Mergers & Acquisitions Stent Grafts Lombard Medical Source Type: news
Update: Aerin Medical raises $6.7m for nasal RF device
Nasal airflow device developer Aerin Medical raised $6.7 million in a new round of equity financing, according to an SEC filing posted last week, and CEO Fred Dinger spoke to MassDevice.com about the company’s trajectory and what the funding is slated for.
Aerin Medical is developing a novel nasal breathing repair device for treating nasal obstruction and reducing rhinitis, using radio frequency energy to reshape interior nasal tissue.
“We have a bipolar RF, which is actually non-invasive. So the product stays on the outside of the tissue, and does not penetrate the tissue. It treats the tissue transmucosaly,” ...
Source: Mass Device - September 16, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Otolaryngology Ear, Nose & Throat Aerin Medical Source Type: news
Arthrex looks to Supreme Court in patent spat with KFx Medical
Arthrex asked the U.S. Supreme Court to reverse a $29 million Federal Circuit Court patent decision from a case against rival KFx Medical, according to court filings submitted Sept. 4.
In the writ of certiorari, Arthrex said that the court’s decision to treat the “reason to combine” question in determining the obviousness of patent validity as a factual issue was “inexplicable,” according to court filings.
The “reason to combine” question is central to whether or not a patent would be obvious to highly trained developers in the field at the time of its conception, which in turn ...
Source: Mass Device - September 21, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Legal News Orthopedics Patent Infringement Arthrex Inc. KFx Medical Source Type: news
Bolton Medical wins CE Mark for Treo stent graft
Bolton Medical said today it won CE Mark approval in the European Union for its Treo abdominal stent-graft for treating abdominal aortic aneurysms.
The endovascular aneurysm repair device is designed as a modular 3-piece system with dual proximal fixation and a unique proximal clasping mechanism, the Sunrise, Fla.-based company said.
“We believe that in EVAR, the tri-modular strategy is the best approach. This is because it allows you to deliver a tailored solution to each patient by selecting specific components to precisely work in that individual anatomy,” R&D veep Scott Rush said in prepared remarks.
T...
Source: Mass Device - September 24, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Blog Bolton Medical Source Type: news
Pryor Medical wins FDA 510(k) for aortic balloon catheter
Minimally-invasive vascular trauma focused Pryor Medical Devices said today it won FDA 510(k) clearance for its ER-Reboa balloon catheter designed to occlude the aorta.
The ER-Reboa is San Antonio, Texas-based Pryor’s flagship product, designed to occlude large vessels using a balloon for treating traumatic injuries, specifically by the critical care and emergency medicine community.
“We are proud to be the first to market with a balloon occlusion catheter designed specifically for this community. They asked for the unique combination of features found on the ER-Reboa catheter, and we look forward to getting it...
Source: Mass Device - October 26, 2015 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Catheters Regulatory/Compliance Vascular Pryor Medical Devices Source Type: news
Supreme Court denies Arthrex in $29m loss to KFx Medical
The U.S. Supreme Court this week declined to review a $29 million patent infringement loss for Arthrex, which wanted the high court to overturn a victory for orthopedics rival KFx Medical.
In petitioning the Supremes, Arthrex argued that the appeals court’s decision to treat the “reason to combine” question in determining the obviousness of patent validity as a factual issue was “inexplicable,” according to court filings.
“The Supreme Court’s ruling has now ended this dispute. KFx has prevailed at each and every step along the way with the superb representation from Joe Jennings, our lead counsel ...
Source: Mass Device - November 18, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Legal News Orthopedics Patent Infringement Arthrex Inc. KFx Medical Source Type: news
Edwards Lifesciences looks to mitral repair with Harpoon Medical stake
Edwards Lifesciences (NYSE:EW) took out a stake with an exclusive option to buy in Harpoon Medical potentially adding a mitral repair device to the mitral valve replacement being developed by recent acquisition CardiAQ Valve Technologies.
Irvine, Calif.-based Edwards did not reveal the size of its stake in Harpoon when it released new guidance earlier this week.
Harpoon, based in Baltimore, is developing a device designed to reduce the amount of time required for mitral valve surgery from 3 to 6 hours down to 60 minutes. The company recently launched a feasibility trial aimed at winning CE Mark approval in the European ...
Source: Mass Device - December 11, 2015 Category: Medical Equipment Authors: Brad Perriello Tags: Replacement Heart Valves Mergers & Acquisitions Cardiovascular Edwards Lifesciences Harpoon Medical Source Type: news
Structural heart: Nobles Medical, HeartStitch tout cardiac suture procedures
Structural heart focused HeartStitch and Nobles Medical today touted separate procedures utilizing cardiac sutures with the company’s Hearstitch ST and Noblestitch EL devices.
Nobles Medical Tech said that the NobleStitch EL device was used in the 1st percutaneous ASD closure and ASA repair and remodeling without the use of an implantable device.
The NobleStitch EL device closes the hole through a minimally invasive cardiovascular suturing procedure, the company said, with a routine cardiac catheterization procedure to secure the closure.
“This was the 1st time we used the NobleStitch cardiovascular suturing d...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Clinical Trials HeartStitch Nobles Medical Technology Source Type: news
Zimmer Biomet closes Cayenne Medical buy
Zimmer Biomet (NYSE:ZBH) said today that it closed its buyout of Cayenne Medical and its soft tissue reconstruction devices for an unspecified amount.
Scottsdale, Ariz.-based Cayenne makes devices for knee and shoulder repair, including the AperFix II, CrossFix II and iFix knee ligament reconstruction and meniscal repair devices and the Quattro device for rotator cuff and labral repairs.
When it announced the buyout in April, Zimmer Biomet said the acquisition would strengthen its sports medicine business.
“As a market leader in musculoskeletal healthcare, the expansion of our sports medicine business with Cayenne...
Source: Mass Device - May 18, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Orthopedics Wall Street Beat Cayenne Medical Zimmer Biomet Source Type: news
Essential Medical wins CE Mark for Manta vascular closure device
Essential Medical said today that it won CE Mark approval in the European Union for its Manta vascular closure device.
The device is designed to close punctures in less than 1 minute, providing immediate hemostasis, using absorbable biomaterials in an “anchor/plug” sealing technology, according to Essential Medical’s website.
“We are thrilled to have approval to sell Manta and have already ramped up production for sales and distribution in Europe. It’s been a great few weeks at Essential Medical with FDA’s approval to start our domestic Manta trial and now CE Mark approval,” president &am...
Source: Mass Device - July 18, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Regulatory/Compliance Vascular Essential Medical Devices Source Type: news
InSeal Medical wins CE Mark for vascular closure device
InSeal Medical said today it won CE Mark approval in the European Union for its InClosure vascular closure device designed to close large bore arterial punctures.
The device is implanted percutaneously and requires no pre-procedure or sheath exchange and features a biodegradable membrane which is coupled to the vessel wall by a thin Nitinol frame, the Israel-based company said.
“The InClosure VCD significantly simplified large bore puncture closure which is still one of the last major challenges in TAVR. Based on our growing experience, the InClosure VCD allows for a smoother and safer TAVR procedure without pre-pro...
Source: Mass Device - August 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Cardiovascular Catheters Regulatory/Compliance InSeal Medical Ltd. Source Type: news
